RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: ankylosing spondylitis
Accession: DOID:7147
browse the term
Definition: A bone inflammation disease that results_in inflammation in the joints of the spine and pelvis. The disease has_symptom pain, has_symptom stiffness in the spine, has_symptom stiffness in the neck, has_symptom stiffness in the hips, has_symptom stiffness in the jaw and has_symptom stiffness in the rib cage. (DO)
Synonyms: exact_synonym: Bechterew Disease; Bechterew syndrome; Bechterew's disease; Bechterews disease; Bekhterev syndrome; Bekhterev's disease; Marie Struempell disease; Marie Strumpell spondylitis; Marie-Strumpell disease; ankylosing spondylarthritides; ankylosing spondylarthritis; ankylosing spondyloarthritides; ankylosing spondyloarthritis; rheumatoid spondylitis; spondylarthritis ankylopoietica; spondylitis ankylopoietica; spondyloarthritis ankylopoietica
related_synonym: ankylosing spondylitis, susceptibility to
primary_id: MESH:D013167
xref: EFO:0003898 ; GARD:9518 ; ICD10CM:M45 ; ICD9CM:720.0 ; MIM:PS106300 ; NCI:C84564 ; ORDO:825
For additional species annotation, visit the
Alliance of Genome Resources .
G
ACE
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
susceptibility
ISO
DNA:deletion:intron:IVS16+1464-1751del (human)
RGD
PMID:22876137
RGD:7829800
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:21122270
RGD:5686891
NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
G
ANO6
anoctamin 6
severity
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP: :rs17095830(human)
CTD RGD
PMID:22138694 PMID:23308121
RGD:9684849
NCBI chr 5:76,112,428...76,337,073
Ensembl chr 5:76,113,236...76,337,069
G
ANTXR2
ANTXR cell adhesion molecule 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20062062 PMID:21743469
NCBI chr 8:137,728,849...137,878,336
Ensembl chr 8:137,618,616...137,878,333
G
ASPN
asporin
susceptibility
ISO
DNA:repeats:exon:
RGD
PMID:20144272
RGD:9684964
NCBI chr 3:42,165,553...42,192,902
Ensembl chr 3:42,165,561...42,192,813
G
CARD9
caspase recruitment domain family member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21743469
G
CRP
C-reactive protein, pentraxin-related
disease_progression
ISO
protein:increased expression:serum:
RGD
PMID:6605119 PMID:22422197
RGD:6482308 RGD:9491788
NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
DNA:polymorphism: :4887C>A (human)
RGD
PMID:12880680
RGD:1581252
NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
G
ERAP1
endoplasmic reticulum aminopeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17952073 PMID:20062062 PMID:21743469 PMID:23291587
NCBI chr 2:103,378,428...103,415,066
Ensembl chr 2:103,378,429...103,408,759
G
ERAP2
endoplasmic reticulum aminopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33550689
NCBI chr 2:103,510,425...103,563,482
Ensembl chr 2:103,510,441...103,564,437
G
FCGR3A
Fc fragment of IgG receptor IIIa
severity
ISO
protein:decreased expression:polymorphonuclear leucocyte
RGD
PMID:8453794
RGD:5508388
NCBI chr 4:88,948,357...88,956,513
G
IGFBP3
insulin like growth factor binding protein 3
ISO
protein:decreased expression:serum
RGD
PMID:9851264
RGD:10402573
NCBI chr18:50,002,921...50,009,425
Ensembl chr18:50,003,022...50,010,690
G
IL12B
interleukin 12B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21743469
NCBI chr16:64,143,268...64,158,929
Ensembl chr16:64,143,268...64,158,929
G
IL17A
interleukin 17A
treatment
ISO
RGD
PMID:24035250
RGD:9068448
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
G
IL1R2
interleukin 1 receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20062062
NCBI chr 3:52,367,434...52,406,393
Ensembl chr 3:52,367,437...52,406,334
G
IL23R
interleukin 23 receptor
no_association
ISO
DNA:SNPs,haplotype:multiple: DNA:SNP: :rs11209026(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17952073 PMID:19522770 PMID:19877036 PMID:20062062
RGD:8549549 RGD:8549630
NCBI chr 6:145,337,765...145,401,909
Ensembl chr 6:145,335,741...145,401,510
G
IL6
interleukin 6
ISO
protein:increased expression:serum:
RGD
PMID:26339141
RGD:12792209
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
IRAK1
interleukin 1 receptor associated kinase 1
susceptibility
ISO
DNA:SNP:enhancer: (rs3027898) (human)
RGD
PMID:20500689
RGD:7495783
NCBI chr X:124,717,604...124,724,855
Ensembl chr X:124,717,612...124,724,860
G
JAK2
Janus kinase 2
susceptibility
ISO
DNA:SNPs, haplotype:introns: (rs1536798, rs10119004, rs7857730) (human)
RGD
PMID:20627814
RGD:6483025
NCBI chr 1:216,849,744...217,002,310
Ensembl chr 1:216,848,689...217,002,148
G
KDM5A
lysine demethylase 5A
susceptibility
ISO
DNA:snps:intron:IVST>A, IVS-1467C>T, IVS+828T>C (rs7134353, rs2284336, rs11062357) (human)
RGD
PMID:24069348
RGD:9588532
NCBI chr 5:67,628,791...67,716,143
Ensembl chr 5:67,629,380...67,715,905
G
MTHFR
methylenetetrahydrofolate reductase
susceptibility
ISO
DNA:SNP:cds:677C>T (human)
RGD
PMID:25060515
RGD:42722610
NCBI chr 6:71,863,637...71,882,118
Ensembl chr 6:71,863,637...71,881,820
G
PGF
placental growth factor
ISO
RGD
PMID:21873332
RGD:6483576
NCBI chr 7:98,149,510...98,162,784
Ensembl chr 7:98,148,994...98,162,741
G
PSMB9
proteasome 20S subunit beta 9
ISO
DNA: snp: rs17587
RGD
PMID:22034108
RGD:6483349
NCBI chr 7:25,072,133...25,077,508
Ensembl chr 7:25,062,367...25,077,523
G
PTGER4
prostaglandin E receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21743469
RGD:6483530
NCBI chr16:25,670,832...25,686,556
Ensembl chr16:25,670,862...25,686,552
G
RUNX3
RUNX family transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21743469
NCBI chr 6:82,531,203...82,595,044
Ensembl chr 6:82,531,559...82,595,026
G
TAP1
transporter 1, ATP binding cassette subfamily B member
ISO
DNA:SNPs: :
RGD
PMID:19480848
RGD:6482250
NCBI chr 7:25,062,772...25,071,989
Ensembl chr 7:25,062,771...25,074,843
G
TAP2
transporter 2, ATP binding cassette subfamily B member
ISO
DNA:SNPs: :
RGD
PMID:19480848
RGD:6482250
NCBI chr 7:25,045,085...25,056,915
Ensembl chr 7:25,045,685...25,056,300
G
TBKBP1
TBK1 binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21743469
NCBI chr12:23,952,966...23,971,495
Ensembl chr12:23,954,605...23,971,494
G
THBD
thrombomodulin
ISO
protein:increased expression:serum
RGD
PMID:21556780
RGD:5684983
NCBI chr17:30,219,870...30,223,499
Ensembl chr17:30,217,303...30,224,099
G
TLR4
toll like receptor 4
ISO
mRNA:increased expression:blood cell:
RGD
PMID:20952467
RGD:7794744
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
G
TLR5
toll like receptor 5
ISO
mRNA:increased expression:blood cell:
RGD
PMID:20952467
RGD:7794744
NCBI chr10:19,387,666...19,410,024
Ensembl chr10:19,387,666...19,410,024
G
TNFRSF1B
TNF receptor superfamily member 1B
ISO
RGD
PMID:21317434
RGD:5131280
NCBI chr 6:72,195,420...72,231,146
Ensembl chr 6:72,195,435...72,231,147
G
VIP
vasoactive intestinal peptide
ISO
protein:increased expression:plasma
RGD
PMID:20340024
RGD:5685387
NCBI chr 1:13,611,786...13,620,250
Ensembl chr 1:13,611,311...13,620,269
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all